Aclaris therapeutics announces formation of new scientific advisory board

Wayne, pa., dec. 15, 2020 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced the formation of a new scientific advisory board consisting of stanley cohen, md, marco colonna, md, james krueger, md, phd, and michael weinblatt, md.
ACRS Ratings Summary
ACRS Quant Ranking